Pitfalls of enzyme-based molecular anticancer dietary manipulations: Food for thought

Mutation Research - Reviews in Mutation Research

Volumn 543, Issue 3, 2003, Pages 181-189

  Paolini, Moreno ^a   Nestle, Marion ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Cancer; Chemoprevention; Dietary patterns; Metabolizing enzymes; Mutagenesis; Phytochemicals

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RISK; CHEMOPROPHYLAXIS; DETOXIFICATION; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; ENZYME METABOLISM; ENZYME SPECIFICITY; FOOD; GENETIC POLYMORPHISM; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; MUTAGENESIS; NUTRIENT; PHYSIOLOGY; PHYTOCHEMISTRY; PLANT; PRIORITY JOURNAL; REDUCTION; REVIEW; TREE;

EID: 0038350661     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00092-3     Document Type: Review

References (85)

1. Bailar J.C. III, Gornik H.L. Cancer undefeated. New Engl. J. Med. 336:1997;1569-1574.
2. McGinnis J.M., Foege W.H. Actual causes of death in the United States. J. Am. Med. Assoc. 270:1993;2207-2212.
3. World Cancer Research Foundation and American Institute for Cancer Research, Food nutrition and the prevention of cancer: a global perspective, World Cancer Research Foundation and American Institute for Cancer Research, Washington, DC, 1997.
4. American Cancer Society Advisory Committee on Diet, Nutrition and cancer prevention, Ca Cancer J. Clin. 46 (1996) 325-341.
5. Nestle M. Dietary recommendations for cancer prevention: public policy implementation. J. Natl. Cancer Inst. Monogr. 12:1992;153-157.
6. Nestle M. Broccoli sprouts as inducers of carcinogen-detoxifying enzyme systems: clinical, dietary, and policy implications. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11149-11151.
7. Peto R., Doll R.J., Buckley J.D., Sporn M.B. Can dietary beta-carotene materially reduce human cancer rates? Nature. 290:1981;201-208.
8. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
9. Morse M.A., Stoner G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis. 14:1993;1737-1746.
10. Gerhauser C., You M., Liu J.et al. Cancer chemoprevention potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res. 57:1997;272-278.
11. Prestera T., Holtzclaw W.D., Zhang Y., Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2965-2969.
12. Kelloff G.J., Boone C.W., Crowell J.A.et al. New agents for cancer chemoprevention. J. Cell. Biochem. 26(Suppl.):1996;1-28.
13. Gerhauser C., You M., Liu J.et al. Chemopreventive potential of a novel sulforaphane analog. Proc. Am. Assoc. Cancer Res. 37:1996;A189.
14. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3147-3153.
15. Maheo K., Morel F., Langouet S.et al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57:1997;3649-3652.
16. Zhang Y., Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res. 58:1998;4632-4639.
17. Shapiro T.A., Fahey J.W., Wade K.L., Stephenson K.K., Talalay P. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev. 7:1998;1091-1100.
18. Bradlow H.L., Telang N.T., Sepkovic D.W., Osborne M.P. Phytochemicals as modulators of cancer risk. Adv. Exp. Med. Biol. 472:1999;207-221.
19. Hecht S.S. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J. Nutr. 129:1999;768S-774S.
20. Yu R., Lei W., Mandlekar S.et al. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274:1998;27545-27552.
21. Kelloff G.J., Crowell J.A., Steele V.E.et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 130(Suppl. 2S):2000;467S-471S.
22. Gamet-Payrastre L., Li P., Lumeau S.et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60:2000;1426-1433.
23. Kelly V.P., Ellis E.M., Manson M.M.et al. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H: quinone oxidoreductase in rat liver. Cancer Res. 60:2000;957-969.
24. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N.et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99:2002;11908-11913.
25. Jang M., Cai L., Udeani G.O.et al. Cancer chemoprevention activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
26. Verhoeven D.T., Verhagen H., Goldbohm R.A.et al. Review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact. 10:1997;79-129.
27. Verhoeven D.T., Goldbohm R.A., van Poppel G.et al. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol. Biomarkers Prev. 5:1996;733-748.
28. Steinkellner H., Rabot S., Freywald C., Nobis E., Scharf G., Chabicovsky M., Knasmuller S., Kassie F. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat. Res. 480-481:2001;285-297.
29. Barcelo S., Gardiner J.M., Gescher A., Chipman J.K. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis. 17:1996;277-282.
30. Kall M.A., Vang O., Clausen J. Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine. Carcinogenesis. 17:1996;793-799.
31. National Research Council Diet, Nutrition and Cancer, National Academy Press, Washington, DC, 1982.
32. Tadi P.P., Teel R.W., Lau B.H.S. Organosulfur compounds of garlic modulate mutagenesis, metabolism, and DNA binding of aflatoxin B1. Nutr. Cancer. 15:1991;87-95.
33. Hong J.Y., Smith T., Lee M.J.et al. Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. Cancer Res. 51:1991;1509-1514.
34. Hernaez J., Xu M., Dashwood R. Effects of tea and chlorophyllin on the mutagenicity of N-hydroxy-IQ: studies of enzyme inhibition, molecular complex formation, and degradation/scavenging of the active metabolites. Environ. Mol. Mut. 30:1997;468-474.
35. Paolini M. Brussels sprouts: an exceptionally rich source of ambiguity for anticancer strategies. Toxicol. Appl. Pharmacol. 152:1998;293-294.
36. Paolini M., Legator M.S. Healthy broccoli? Nature. 357:1992;448.
37. Faulkner K., Mithen R., Williamson G. Selective increase of the potential anticarcinogen 4-methylsulphinylbutyl glucosinolate in broccoli. Carcinogenesis. 19:1998;605-609.
38. Guengerich F.P. Enzymatic activation of chemicals to toxic metabolites. CRC Crit. Rev. Toxicol. 14:1985;259-307.
39. Cantelli-Forti G., Hrelia P., Paolini M. The pitfall of detoxifying enzymes. Mutat. Res. 402:1998;179-183.
40. Hirose M., Yamaguchi T., Kimoto N.et al. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats. Int. J. Cancer. 77:1998;773-777.
41. Kassie F., Pool-Zobel B., Parzefall W., Knasmuller S. Genotoxic effects of benzyl isothiocyanate, a natural chemopreventive agent. Mutagenesis. 14:1999;595-604.
42. Gamet-Payrastre L., Li P., Lumeau S.et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60:2000;1426-1433.
43. Paolini M., Pozzetti L., Silingardi P., Della Croce C., Bronzetti G., Cantelli-Forti G. Isolation of a novel metabolizing system enriched in phase-II enzymes for short-term genotoxicity bioassays. Mutat. Res. 413:1998;205-217.
44. Thier R., Muller M., Taylor J.B., Pemble S.E., Ketterer B., Guengerich F.P. Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase. Chem. Res. Toxicol. 8:1995;465-472.
45. Tannenbaum S.R. Predictors of dietary heterocyclic amine intake in three prospective cohorts. Cancer Epidemiol. Biomarkers Prev. 7:1998;1153-1154.
46. Lampe J.W., King I.B., Li S.et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis. 21:2000;1157-1162.
47. Bailey G.S., Hendricks J.D., Shelton D.W., Nixon J.E., Pawlowski N.E. Enhancement of carcinogenesis by natural anticarcinogen indole-3-carbinol. J. Natl. Cancer Inst. 78:1987;931-934.
48. Dashwood R.H. Indole-3-carbinol: anticarcinogen or tumor promoter in brassica vegetables? Chem. Biol. Interact. 110:1998;1-5.
49. Yang C.S. Tea and cancer. J. Natl. Cancer Inst. 85:1993;1038-1049.
50. Fiala E.S., Bobotas G., Kulakis C., Wattenberg L.W., Weisburger J.H. Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1, 2-dimethylhydrazine. Biochem. Pharmacol. 26:1977;1763-1768.
51. Wargovich M.J. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis. 8:1987;487-489.
52. Guengerich F.P., Kim D.H. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 11:1990;2275-2279.
53. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans, Coffee, tea, mate, methylxanthines and methylglyoxal. Lyon, 1990, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. No. 51, International Agency for Research on Cancer, Lyon, 1991, pp. 207-271.
54. Bu-Abbas A., Clifford M.N., Walker R., Ioannides C. Modulation of hepatic cytochrome P450 activity and carcinogen bioactivation by black and decaffeinated black tea. Env. Toxicol. Pharmacol. 7:1999;41-47.
55. Goldbohm A., Hertog M.G.L., Brandts H.A.M., van Poppel G., van den Brandt P. Consumption of black tea and cancer risk: a prospective cohort study. J. Natl. Cancer Inst. 88:1996;93-100.
56. Yang C.S., Smith T.J., Hong J.Y., Chen L. Cancer prevention through modulation of xenobiotic metabolising enzymes: opportunities and limitations. Proc. Annu. Meet. Am. Assoc. Cancer Res. 37:1996;665-666.
57. Nebert D.W. Drug metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. 47:1994;25-27.
58. Nebert D.W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res. 247:1991;267-281.
59. Daly A.K., Cholerton S., Gregory W., Idle J.R. Metabolic polymorphisms. Pharmacol. Ther. 57:1993;129-160.
60. Wormhoudt L.W., Commandeur J.N.M., Vermeulen N.P.E. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit. Rev. Toxicol. 29:1999;59-124.
61. Paolini M. Acetylator genotype and Parkinson's disease. Lancet. 351:1998;141-142.
62. Paolini M., Biagi G.L., Cantelli-Forti G. Glutathione transferase polymorphism and Parkinson's disease. Lancet. 353:1999;71-72.
63. Paolini M., Biagi G.L., Bauer C., Cantelli-Forti G. Enzyme evolution and cancer: a hypothesis to explain why natural carcinogens are more potent than synthetic ones. Life Sci. 63:1998;2141-2146.
64. Ames B.N., Profet M., Gold L.S. Dietary pesticides (99.99% all natural). Proc. Natl. Acad. Sci. U.S.A. 87:1990;7777-7781.
65. S.A. Gerrior, C. Zizza, Nutrient content of the US food supply 1909-90, US Department of Agriculture, Washington, DC, 1994.
66. Collins A.R., Olmedilla B., Southon S., Granado F., Duthie S.Y. Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis. 19:1998;2159-2162.
67. Hennekens C.H., Buring J.E., Manson J.E.et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New Engl. J. Med. 334:1996;1145-1149.
68. Omenn G.S., Goodman G.E., Thornquist M.D.et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med. 334:1996;1150-1155.
69. Rowe P.M. Beta-carotene takes a collective beating. Lancet. 347:1996;249.
70. Omenn G.S., Goodman G.E., Thornquist M.D.et al. Risk factors for lung cancer and for intervention effects in CARET. J. Natl. Cancer Inst. 88:1996;1550-1559.
71. Hinds T.S., West W.L., Knight E.M. Carotenoids and retinoids: a review of research, clinical, and public health applications. J. Clin. Pharmacol. 37:1997;551-558.
72. Paolini M., Abdel-Rahman S.Z., Cantelli-Forti G., Legator M.S. Chemoprevention or antichemoprevention? A salutary warning from the beta-carotene experience. J. Natl. Cancer Inst. 93:2001;1110-1111.
73. Omaye S.T., Krinsky N.I., Kagan V.E., Mayne S.T., Liebler D.C., Bidlack W.R. Beta-carotene: friend or foe? Fund. Appl. Toxicol. 40:1997;163-174.
74. Baker D.L., Krol E.S., Jacobsen N., Liebler D.C. Reactions of beta-carotene with cigarette smoke oxidants. Identification of carotenoid oxidation products and evaluation of the prooxidant/antioxidant effect. Chem. Res. Toxicol. 12:1999;535-543.
75. Wang X.D., Russell R.M. Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr. Rev. 57:1999;263-272.
76. Lee I.M., Cook N.R., Manson J.E., Buring J.E., Hennekens C.H. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study. J. Natl. Cancer Inst. 91:1999;2102-2106.
77. Marshall J.R. Beta-carotene: a miss for epidemiology. J. Natl. Cancer Inst. 91:1999;2068-2069.
78. Vainio H. Chemoprevention of cancer: lessons to be learned from beta-carotene trials. Toxicol. Lett. 15:2000;513-517.
79. Goodman G.E. Prevention of lung cancer. Crit. Rev. Oncol. Hematol. 33:2000;187-197.
80. Paolini M., Cantelli-Forti G., Perocco P., Pedulli G.F., Abdel-Rahman S.Z., Legator M.S. Co-carcinogenic effect of beta-carotene. Nature. 398:1999;760-761.
81. Wang X.D., Liu C., Bronson R.T., Smith D.E., Krinsky N.I., Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91:1999;60-66.
82. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 392:1998;559.
83. Paolini M., Pozzetti L., Pedulli G.F., Marchesini E., Cantelli-Forti G. The nature of prooxidant activity of vitamin C. Life Sci. 64:1999;273-278.
84. Eberhard M.V., Lee C.Y., Liv H.L. Antioxidant activity of fresh apples. Nature. 405:2000;903-904.
85. Lee S.H., Oe T., Blair I.A. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science. 292:2001;2083-2086.